
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 980 | 980 | 882 | 870 | 1160 | - |
Fund Return | -2.02% | -2.02% | -11.81% | -4.53% | 3.02% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cleome Index USA Equities Y EUR Acc | 2.49B | -9.42 | 7.61 | 10.37 | ||
Cleome Index USA Equities Z EUR Acc | 2.49B | -9.12 | 9.08 | 11.65 | ||
LU2197358042 | 2.49B | -9.13 | 8.99 | - | ||
Cleome Index USA Equities R EUR Acc | 2.49B | -9.19 | 8.75 | 11.26 | ||
LU0654531184 | 1.9B | -7.88 | 5.23 | 7.59 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage C EUR H AccE | 59.11B | -2.18 | 10.05 | 7.30 | ||
Invesco JapEqAdvantage A EUR H AccE | 59.11B | -2.42 | 9.05 | 6.45 | ||
LU1482751903 | 394.41M | -5.40 | 9.27 | - | ||
LU1841614867 | 239.11M | -5.55 | 8.31 | - | ||
Morgan Stanley Global Brands CH | 19.46B | 0.83 | 0.74 | 6.17 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.34 | 732.41 | +1.60% | |
AstraZeneca | GB0009895292 | 5.01 | 10,008.0 | -0.10% | |
Merck&Co | US58933Y1055 | 4.38 | 79.18 | +2.10% | |
Novo Nordisk B | DK0062498333 | 4.31 | 420.3 | +2.64% | |
Gilead | US3755581036 | 4.29 | 103.63 | +2.20% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review